DeDora Capital’s Exact Sciences EXAS Stock Holding History

DeDora Capital’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-190	Closed	-$13K	–	204
2022 Q1	$13K	Buy	+190	New	+$13.9K	0.01%	288

Other funds holding EXAS

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

DeDora Capital's EXAS Position: Q2 2022 in Review

DeDora Capital sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 190 shares — an estimated $13K sold.

DeDora Capital first reported a position in EXAS in Q1 2022 and held it in 1 quarter. The position peaked at $13K in Q1 2022. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

DeDora Capital reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 190 Exact Sciences shares in Q2 2022, an estimated $13K.
DeDora Capital first reported a position in Exact Sciences in Q1 2022 and held it in 1 quarter.
DeDora Capital's Exact Sciences position peaked at $13K in Q1 2022.
501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.